1. Toward a holistic view of multiscale breast cancer molecular biomarkers
   Xiaofeng Dai et al, 2019, Biomarkers in Medicine CrossRef
2. Dysregulated expression of repetitive DNA in ER+/HER2- breast cancer
   Cihangir Yandım et al, 2019, Cancer Genetics CrossRef
3. Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines
   Nadia A. Thabet et al, 2019, Toxicology and Applied Pharmacology CrossRef
4. Role of organophosphorous pesticides and acetylcholine in breast carcinogenesis
   Gloria M. Calaf, 2021, Seminars in Cancer Biology CrossRef
5. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway
   Han-Tsang Wu et al, 2020, The American Journal of Chinese Medicine CrossRef
6. CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
   G. M. Calaf, 2018, Siberian journal of oncology CrossRef
7. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation
   Woo-Jeong Jeong et al, 2019, Nature Communications CrossRef
8. Curcumin rescues breast cells from epithelial‑mesenchymal transition and invasion induced by anti‑miR‑34a
   Marcela Gallardo et al, 2019, International Journal of Oncology CrossRef
9. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma
   Kazuki Tashiro et al, 2020, Odontology CrossRef
10. Glyphosate mimics 17β-estradiol effects promoting estrogen receptor alpha activity in breast cancer cells
    Juan P. Muñoz et al, 2023, Chemosphere CrossRef
11. Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice
    Hao-Jun Xiong et al, 2023, Military Medical Research CrossRef